Capital International Sarl Sarepta Therapeutics, Inc. Transaction History
Capital International Sarl
- $4.13 Billion
- Q4 2024
A detailed history of Capital International Sarl transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital International Sarl holds 35,256 shares of SRPT stock, worth $3.77 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
35,256
Previous 18,848
87.05%
Holding current value
$3.77 Million
Previous $2.35 Million
82.07%
% of portfolio
0.1%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.1 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$972 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$930 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$463 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$435 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.37B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...